Mistry Hiten D, Gill Carolyn A, Kurlak Lesia O, Seed Paul T, Hesketh John E, Méplan Catherine, Schomburg Lutz, Chappell Lucy C, Morgan Linda, Poston Lucilla
Division of Women׳s Health, King׳s College London, Women׳s Health Academic Centre, KHP, London SE1 7EH, UK.
Division of Women׳s Health, King׳s College London, Women׳s Health Academic Centre, KHP, London SE1 7EH, UK.
Free Radic Biol Med. 2015 Jan;78:147-55. doi: 10.1016/j.freeradbiomed.2014.10.580. Epub 2014 Nov 6.
Preeclampsia is a pregnancy-specific condition affecting 2-7% of women and a leading cause of perinatal and maternal morbidity and mortality. Deficiencies of specific micronutrient antioxidant activities associated with copper, selenium, zinc, and manganese have previously been linked to preeclampsia at the time of disease. Our aims were to investigate whether maternal plasma micronutrient concentrations and related antioxidant enzyme activities are altered before preeclampsia onset and to examine the dependence on genetic variations in these antioxidant enzymes. Predisease plasma samples (15±1 weeks׳ gestation) were obtained from women enrolled in the international Screening for Pregnancy Endpoints (SCOPE) study who subsequently developed preeclampsia (n=244) and from age- and BMI-matched normotensive controls (n=472). Micronutrient concentrations were measured by inductively coupled plasma mass spectrometry; associated antioxidant enzyme activities, selenoprotein-P, ceruloplasmin concentration and activity, antioxidant capacity, and markers of oxidative stress were measured by colorimetric assays. Sixty-four tag-single-nucleotide polymorphisms (SNPs) within genes encoding the antioxidant enzymes and selenoprotein-P were genotyped using allele-specific competitive PCR. Plasma copper and ceruloplasmin concentrations were modestly but significantly elevated in women who subsequently developed preeclampsia (both P<0.001) compared to controls (median (IQR), copper, 1957.4 (1787, 2177.5) vs 1850.0 (1663.5, 2051.5) µg/L; ceruloplasmin, 2.5 (1.4, 3.2) vs 2.2 (1.2, 3.0) µg/ml). There were no differences in other micronutrients or enzymes between groups. No relationship was observed between genotype for SNPs and antioxidant enzyme activity. This analysis of a prospective cohort study reports maternal micronutrient concentrations in combination with associated antioxidant enzymes and SNPs in their encoding genes in women at 15 weeks׳ gestation that subsequently developed preeclampsia. The modest elevation in copper may contribute to oxidative stress, later in pregnancy, in those women that go on to develop preeclampsia. The lack of evidence to support the hypothesis that functional SNPs influence antioxidant enzyme activity in pregnant women argues against a role for these genes in the etiology of preeclampsia.
子痫前期是一种妊娠特有的疾病,影响2%至7%的孕妇,是围产期和孕产妇发病及死亡的主要原因。先前有研究表明,与铜、硒、锌和锰相关的特定微量营养素抗氧化活性缺乏与疾病发生时的子痫前期有关。我们的目的是调查子痫前期发病前孕妇血浆微量营养素浓度及相关抗氧化酶活性是否发生改变,并研究这些抗氧化酶的基因变异依赖性。从参与国际妊娠结局筛查(SCOPE)研究的女性中获取发病前的血浆样本(妊娠15±1周),这些女性随后发展为子痫前期(n = 244),并选取年龄和体重指数匹配的血压正常对照组(n = 472)。通过电感耦合等离子体质谱法测量微量营养素浓度;采用比色法测量相关抗氧化酶活性、硒蛋白-P、铜蓝蛋白浓度和活性、抗氧化能力以及氧化应激标志物。使用等位基因特异性竞争性PCR对编码抗氧化酶和硒蛋白-P的基因内的64个标签单核苷酸多态性(SNP)进行基因分型。与对照组相比,随后发展为子痫前期的女性血浆铜和铜蓝蛋白浓度虽有适度但显著升高(均P<0.001)(中位数(四分位间距),铜,1957.4(1787,2177.5) vs 1850.0(1663.5,2051.5)μg/L;铜蓝蛋白,2.5(1.4,3.2) vs 2.2(1.2,3.0)μg/ml)。两组之间其他微量营养素或酶无差异。未观察到SNP基因型与抗氧化酶活性之间的关系。这项前瞻性队列研究分析报告了妊娠15周时随后发展为子痫前期的女性的母体微量营养素浓度及其编码基因中的相关抗氧化酶和SNP。铜的适度升高可能在妊娠后期对发展为子痫前期的女性造成氧化应激。缺乏证据支持功能性SNP影响孕妇抗氧化酶活性这一假设,这表明这些基因在子痫前期病因学中不起作用。